The regulatory approval arrived on the back of a clinical trial which found that participants lost an average of 14 per cent of their body weight during 64 weeks
Compounded semaglutide from PlexusDx originates from licensed 503A compounding pharmacies that operate under state pharmacy boards and federal USP standards, ensuring sterility, potency, and purity without FDA pre-market approval
As of March 2026, BPC-157 has transitioned into an "investigational clinical staple," backed by a series of foundational safety trials and specialized pilot studies
Wegovy (starting price $260 per month), Mounjaro and Zepbound (both about $700 a month) have been knocked back by the PBS because they cost more and might need to be taken for life, whether it's for diabetes or weight loss
Journal of Orthopaedic Research , 32(9), 11541161
Yet for more than a decade, questions about possible links to pancreatitis have persisted